RecruitingNCT01574053
Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort
Studying Huntington's Disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- CHDI Foundation, Inc.
- Principal Investigator
- Bernhard G Landwehrmeyer, MD, PhDUniversity of Ulm
- Enrollment
- 35000 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2012 – 2062
Study locations (30)
- University of Alabama, Birmingham, Alabama, United States
- St. Joseph's Hospital and Medical Center, Phoenix, Arizona, United States
- University of California - Irvine Medical Center, Irvine, California, United States
- Loma Linda Medical Center, Loma Linda, California, United States
- University of California - Los Angeles, Los Angeles, California, United States
- University of California - Davis, Sacramento, California, United States
- University of California - San Diego, San Diego, California, United States
- University of California - San Francisco, San Francisco, California, United States
- Cenexel Rocky Mountain Clinical Research, LLC, Englewood, Colorado, United States
- University of Connecticut, Farmington, Connecticut, United States
- Georgetown University, Washington D.C., District of Columbia, United States
- University of Florida Board of Trustees, Gainesville, Florida, United States
- University of Miami, Miami, Florida, United States
- University of South Florida, HDSA Center of Excellence at USF, Tampa, Florida, United States
- Emory University, Wesley Woods Health Center, Atlanta, Georgia, United States
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01574053 on ClinicalTrials.govOther trials for Huntington's Disease
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1NCT07246941A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RG6496 in Huntington's DiseaseHoffmann-La Roche
- RECRUITINGNANCT06807892Comparison of Two Cognitive-Motor Rehabilitation Approaches Via Exergames: a Study of Cognitive, Motor and Behavioral Functions in Huntington's Disease PatientsUniversity Hospital, Angers
- RECRUITINGNANCT07299682Facilitating Effective Eating With DoddleBags: A Single-Arm Acceptability Study Of DoddleBags to Assess Impact on Self Feeding Behaviours in a Huntington's Disease PopulationUniversity of Hull
- RECRUITINGPHASE1NCT06585449A Study to Evaluate ALN-HTT02 in Adult Patients With Huntington's DiseaseAlnylam Pharmaceuticals
- ACTIVE NOT RECRUITINGNCT07503743Biology-Driven Cognitive Profiling in Huntington's DiseaseFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT04120493Safety and Proof-of-Concept (POC) Study With AMT-130 in Adults With Early Manifest Huntington's DiseaseUniQure Biopharma B.V.
- RECRUITINGNCT02855476HDClarity: a Multi-site Cerebrospinal Fluid Collection Initiative to Facilitate Therapeutic Development for Huntington's DiseaseUniversity College, London